五联疗法治疗重症急性高脂血症性胰腺炎
本研究为单中心回顾性研究,纳入2007年1月至2016年12月ICU收治的HL-SAP患者,比较单纯常规治疗(对照组63例)与常规治疗联合五联疗法(五联疗法组25例)的疗效。五联疗法包括血液净化、降脂药、低分子肝素、胰岛素及芒硝(Pixiao)全腹覆盖。结果显示五联疗法组血清淀粉酶、甘油三酯、白细胞计数、C反应蛋白及血糖显著降低,血清钙显著升高;治疗第7天血清淀粉酶和血清钙变化组间差异显著;五联疗法组第2天和第7天甘油三酯降幅大于对照组;五联疗法组住院时间显著缩短。作者认为五联疗法联合常规治疗可能优于单纯常规治疗。
要点
- 在常规治疗基础上加用五联疗法(血液净化、降脂药、低分子肝素、胰岛素、芒硝全腹覆盖)可能改善HL-SAP患者的血清生物标志物。
- 五联疗法组第2天和第7天血清甘油三酯降幅均大于对照组。
- 治疗第7天血清淀粉酶和血清钙的变化在五联疗法组与对照组之间差异显著。
- 五联疗法组住院时间显著短于对照组。
- 该研究为单中心回顾性研究,样本量有限(五联疗法组25例,对照组63例),结论需进一步验证。
适用人群与场景
- ICU收治的重症急性高脂血症性胰腺炎(HL-SAP)患者,研究期间为2007年1月至2016年12月。
- 接受常规治疗或常规治疗联合五联疗法的HL-SAP患者。
处置流程与药物剂量
- 五联疗法组在常规治疗基础上接受:血液净化、降脂药、低分子肝素、胰岛素、芒硝(Pixiao)全腹覆盖。
- 对照组仅接受常规治疗。
研究设计与关键结果
- 研究类型:单中心回顾性研究;样本量:五联疗法组25例,对照组63例;人群:ICU收治的HL-SAP患者;干预:常规治疗联合五联疗法 vs 单纯常规治疗。
- 五联疗法组血清淀粉酶、甘油三酯、白细胞计数、C反应蛋白及血糖显著降低,血清钙显著升高。
- 治疗第7天血清淀粉酶和血清钙的变化在五联疗法组与对照组之间差异显著。
- 五联疗法组第2天和第7天血清甘油三酯降幅均大于对照组。
- 五联疗法组住院时间显著短于对照组。
证据类型、等级与局限
- 证据类型:单中心回顾性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,对于HL-SAP患者,在常规治疗基础上加用五联疗法可能优于单纯常规治疗,可改善血清生物标志物和临床结局。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: The purpose of our study is to evaluate the efficacy of penta-therapy for HL-SAP in a retrospective study.
METHODS: Retrospective study between January 2007 and December 2016 in a hospital intensive care unit. HL-SAP patients were assigned to conventional treatment alone (the control group) or conventional treatment with the experimental protocol (the penta-therapy group) consists of blood purification, antihyperlipidemic agents, low-molecular weight heparin, insulin, covering the whole abdomen with Pixiao (a traditional Chinese medicine). Serum triglyceride, serum calcium, APACHE II score, SOFA score, Ranson score, and other serum biomarkers were evaluated. The hospital length of stay, local complications, systematic complications, rate of recurrence, overall mortality, and operation rate were considered clinical outcomes.
RESULTS: 63 HL-SAP patients received conventional treatment alone (the control group) and 25 patients underwent penta- therapy combined with conventional treatment (the penta-therapy group). Serum amylase, serum triglyceride, white blood cell count, C-reactive protein, and blood sugar were significantly reduced, while serum calcium was significantly increased with penta-therapy. The changes in serum amylase, serum calcium were significantly different between the penta-therapy and control group on 7th day after the initiation of treatment. The reduction in serum triglyceride in the penta-therapy group on the second day and 7th day were greater than the control group. Patients in the penta-therapy group had a significantly shorter length of hospital stay.
CONCLUSION: This study suggests that the addition of penta-therapy to conventional treatment for HL-SAP may be superior to conventional treatment alone for improvement of serum biomarkers and clinical outcomes.
参考来源
- Lu J, Xie Y, Du J, et al. Penta-therapy for severe acute hyperlipidemic pancreatitis. Am J Emerg Med. 2018. PMID: 29409663. doi:10.1016/j.ajem.2018.01.092
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。